Epidermal growth factor receptor (EGFR) protein expression, evaluated by immunohistochemistry (IHC), has been shown to have prognostic significance in patients with colon cancer (Watanabe et al, 2001). This evidence concerns the gene EGFR and colonic neoplasm.